Investing Profile

Heather Preston


Managing Partner at Pivotal BioVentures Francisco, California
Photo of Heather Preston, Managing Partner at Pivotal bioVenture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
McKinsey & Company Network
University of Oxford Network
New Enterprise Associates (NEA) Network
$100K - $5.0M
CompanyStageDateRound SizeTotal Raised
Arkuda Therapeutics
Series BFeb 2022$64M
Co-investors: Bruce Booth (Atlas Venture)
Avalyn Pharma
Series BApr 2020$36M
Co-investors: Robert Mittendorff (B Capital Group)
Series BMar 2020$110M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Kush Parmar (5am Ventures)
Fusion Pharmaceuticals
Series BApr 2019$110M
Co-investors: Chau Khuong (OrbiMed)
Karuna Therapeutics
Series BMar 2019$68M
Co-investors: Robert Nelsen (ARCH Venture Partners), Steve Paul (Third Rock Ventures), James Healy (Sofinnova Investments)
Azura Ophthalmics
Series BOct 2017$16M
Entasis Therapeutics
Series BSep 2017$32M
Co-investors: Heather Behanna (SR One), Tracy Saxton (Dolby Family Ventures)
Alder Biopharmaceuticals
Series DApr 2012$38M
Series CDec 2007$40M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners)
Managing Partner Pivotal BioVentures2018 - Present
Partner and Managing Director TPG Biotech2005 - 2018
Entrepreneur In Residence New Enterprise Associates (NEA)2002 - 2003
Engagement Manager McKinsey & Company1997 - 2002
Gastroenterologist and Hepatologist University of California, San Francisco1996 - 1997
Internal Medicine Physician Massachusetts General Hospital1994 - 1996
Postdoctoral Research Fellow Harvard University1991 - 1994
University of Oxford MD Medicine
St Bartholomews Hospital Medical School, University of London B.Sc. Hons Biochemistry